BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2006
View Archived Issues
Ostabolin-C safe, active in healthy, older volunteers
Read More
Oral gallium superior to intravenous formulation in vitro
Read More
Mechanism of PT-100 antitumor activity explored
Read More
Antitoxicity, inhibitory effects of As4O6 investigated in vitro
Read More
Neuropeptide Y Y1 receptor a potential target for breast cancer treatment
Read More
Evaluation of Coenzyme Q10 in Duchenne muscular dystrophy moves to phase III
Read More
Positive interim phase II results for CUV-1647 in polymorphous light eruption
Read More
Chemokine Therapeutics reacquires CTCE-0214 rights
Read More
YM BioSciences to acquire Eximias Pharmaceutical
Read More
Athenagen acquires Osprey Pharmaceutical
Read More
GSK obtains rights to Japan Tobacco drug in MEK inhibition
Read More
Pfizer to acquire rights to fesoterodine for overactive bladder
Read More
FermaVir receives FDA advice on development of shingles drug CF-1743
Read More
Cortex receives written confirmation on CX-717 clinical hold
Read More
Fast track designation for TheraQuest's Tramadol ER
Read More
New phase III trial studies Velcade with rituximab in follicular lymphoma
Read More
Eprodisate NDA filed and granted priority review for AA amyloidosis
Read More
American Pharmaceutical Partners and American BioScience merge
Read More
New gamma-secretase inhibitor markedly reduces Abeta levels in vivo
Read More
Novel agents for urological disorders disclosed in recent patent literature
Read More
Recent patents impart new agents for obesity and lipoprotein disorders
Read More
Fast track status for thrombin receptor antagonist SCH-530348
Read More
FDA accepts Novartis' Rasilez submission for review
Read More
Roche submits BLA for CERA
Read More
New anticoagulant agents emerge from sanofi-aventis R&D
Read More
Oncolytic adenoviruses plus cytostatic agents as novel approach for prostate cancer
Read More
New potent, highly selective Tie-2 kinase inhibitor from Amgen demonstrates in vivo efficacy
Read More